• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关巨噬细胞在免疫治疗中的作用。

Tumor-associated macrophages in immunotherapy.

机构信息

National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (Cultivation), Guangdong Province Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China.

出版信息

FEBS J. 2021 Nov;288(21):6174-6186. doi: 10.1111/febs.15726. Epub 2021 Feb 13.

DOI:10.1111/febs.15726
PMID:33492779
Abstract

Tumor-associated macrophages (TAMs) are essential components of the tumor microenvironment involved in the progression and metastasis of cancer. They are intimately involved in angiogenesis and immunosuppression in normal and malignant tissues, as well as pro-fibrotic activities. With the development of immunotherapy, eradication of cancer cells through activation of the innate immune system has achieved inspiring results, whereas only a handful of patients show a durable response. The tumor-suppressive environment has been investigated with respect to playing a vital role in cancer relapse. In this review, we uncover the heterogeneity of the origin of TAMs, as well as the functions of TAMs in tumor progression associated with intricate regulatory networks in the tumor microenvironment, aiming to inspire therapeutic insight for tumor immunotherapy.

摘要

肿瘤相关巨噬细胞(TAMs)是肿瘤微环境的重要组成部分,参与癌症的进展和转移。它们在正常和恶性组织中的血管生成和免疫抑制中密切相关,并且具有促纤维化活性。随着免疫疗法的发展,通过激活先天免疫系统来消除癌细胞已经取得了令人鼓舞的结果,但是只有少数患者表现出持久的反应。人们已经研究了肿瘤抑制环境在癌症复发中所起的重要作用。在这篇综述中,我们揭示了 TAMs 起源的异质性,以及 TAMs 在肿瘤进展中的功能,以及肿瘤微环境中复杂的调控网络,旨在为肿瘤免疫治疗提供治疗思路。

相似文献

1
Tumor-associated macrophages in immunotherapy.肿瘤相关巨噬细胞在免疫治疗中的作用。
FEBS J. 2021 Nov;288(21):6174-6186. doi: 10.1111/febs.15726. Epub 2021 Feb 13.
2
Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.肿瘤微环境与肿瘤相关巨噬细胞之间的代谢调控串扰。
Theranostics. 2021 Jan 1;11(3):1016-1030. doi: 10.7150/thno.51777. eCollection 2021.
3
Single-cell transcriptional atlas of tumor-associated macrophages in breast cancer.乳腺癌肿瘤相关巨噬细胞的单细胞转录组图谱。
Breast Cancer Res. 2024 Sep 4;26(1):129. doi: 10.1186/s13058-024-01887-6.
4
Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.肿瘤相关巨噬细胞:癌症免疫治疗策略的有前途的靶点。
Pharmacol Res. 2020 Nov;161:105111. doi: 10.1016/j.phrs.2020.105111. Epub 2020 Oct 13.
5
Tumor-associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire.肿瘤相关巨噬细胞:肿瘤微环境中先天免疫系统的失控哨兵。
Cell Biol Int. 2024 Oct;48(10):1406-1449. doi: 10.1002/cbin.12226. Epub 2024 Jul 25.
6
Mechanistic studies of tumor-associated macrophage immunotherapy.肿瘤相关巨噬细胞免疫治疗的机制研究。
Front Immunol. 2024 Sep 30;15:1476565. doi: 10.3389/fimmu.2024.1476565. eCollection 2024.
7
Macrophage-based cancer immunotherapy: Challenges and opportunities.基于巨噬细胞的癌症免疫疗法:挑战与机遇。
Exp Cell Res. 2024 Sep 1;442(1):114198. doi: 10.1016/j.yexcr.2024.114198. Epub 2024 Aug 3.
8
Decoding the spatiotemporal heterogeneity of tumor-associated macrophages.解析肿瘤相关巨噬细胞的时空异质性。
Mol Cancer. 2024 Jul 27;23(1):150. doi: 10.1186/s12943-024-02064-1.
9
Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.癌症免疫疗法:通过基因沉默靶向肿瘤相关巨噬细胞。
Methods Mol Biol. 2020;2115:289-325. doi: 10.1007/978-1-0716-0290-4_17.
10
Targeting tumor-associated macrophages for cancer immunotherapy.针对肿瘤相关巨噬细胞的癌症免疫疗法。
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188434. doi: 10.1016/j.bbcan.2020.188434. Epub 2020 Sep 18.

引用本文的文献

1
Single-Cell RNA Sequencing Reveals Potential Mechanism of RUNX3 Reshaping Tumor Microenvironment in Non-small-cell Lung Cancer.单细胞RNA测序揭示RUNX3重塑非小细胞肺癌肿瘤微环境的潜在机制
Ann Surg Oncol. 2025 Sep 7. doi: 10.1245/s10434-025-18034-w.
2
CDH3 promotes the progression of lung adenocarcinoma through driving epithelial-mesenchymal transition progress.CDH3通过推动上皮-间质转化进程促进肺腺癌进展。
J Transl Med. 2025 Aug 8;23(1):887. doi: 10.1186/s12967-025-06750-6.
3
Decoding MHC loss: Molecular mechanisms and implications for immune resistance in cancer.
解读MHC缺失:癌症免疫抵抗的分子机制及其影响
Clin Transl Med. 2025 Jul;15(7):e70403. doi: 10.1002/ctm2.70403.
4
Advances in the interrelated nature of vaginal microecology, HPV infection, and cervical lesions.阴道微生态、人乳头瘤病毒感染与宫颈病变之间相互关系的研究进展
Front Cell Infect Microbiol. 2025 Jun 19;15:1608195. doi: 10.3389/fcimb.2025.1608195. eCollection 2025.
5
Natural saponins and macrophage polarization: Mechanistic insights and therapeutic perspectives in disease management.天然皂苷与巨噬细胞极化:疾病管理中的机制洞察与治疗前景
Front Pharmacol. 2025 May 9;16:1584035. doi: 10.3389/fphar.2025.1584035. eCollection 2025.
6
Cross-Talk Between Tumor Cells and Stellate Cells Promotes Oncolytic VSV Activity in Intrahepatic Cholangiocarcinoma.肿瘤细胞与星状细胞之间的串扰促进肝内胆管癌中的溶瘤性水疱性口炎病毒活性。
Cancers (Basel). 2025 Feb 4;17(3):514. doi: 10.3390/cancers17030514.
7
Targeting macrophage circadian rhythms with microcurrent stimulation to activate cancer immunity through phagocytic defense.通过微电流刺激靶向巨噬细胞昼夜节律,以通过吞噬防御激活癌症免疫。
Theranostics. 2025 Jan 1;15(2):340-361. doi: 10.7150/thno.100748. eCollection 2025.
8
Natural compounds modulate the mechanism of action of tumour-associated macrophages against colorectal cancer: a review.天然化合物调节肿瘤相关巨噬细胞对抗结直肠癌的作用机制:综述。
J Cancer Res Clin Oncol. 2024 Nov 15;150(11):502. doi: 10.1007/s00432-024-06022-8.
9
Integrated analysis reveals prognostic correlation and immune characteristics of a tumor-associated macrophage-based risk signature in triple-negative breast cancer.综合分析揭示了三阴性乳腺癌中基于肿瘤相关巨噬细胞的风险特征的预后相关性和免疫特征。
Transl Cancer Res. 2024 Oct 31;13(10):5214-5232. doi: 10.21037/tcr-24-1037. Epub 2024 Oct 29.
10
Advances in research on factors affecting chimeric antigen receptor T-cell efficacy.嵌合抗原受体 T 细胞疗效影响因素的研究进展。
Cancer Med. 2024 Jun;13(11):e7375. doi: 10.1002/cam4.7375.